Cell death, dysglycemia and myocardial infarction.

Tian, Xiao-Fang; Cui, Ming-Xia; Yang, Shi-Wei; Zhou, Yu-Jie; Hu, DA-Yi.

Afiliação

Tian XF; Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu 730000;
Cui MX; Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu 730000;
Yang SW; 12th Ward, Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029;
Zhou YJ; 12th Ward, Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029;
Hu DY; Department of Cardiology, People's Hospital Affiliated to Peking University, Beijing 100044, P.R. China.

Biomed Rep ; 1(3): 341-346, 2013 May.

Article em En | MEDLINE | ID: mdl-24648945